Biogen (BIIB) said Monday it has signed a 15-year lease for its new global headquarters at Kendall Common in Cambridge, Massachusetts.
The company said it intends to shift its Cambridge-based employees to the new facility when it opens in 2028.
Biogen said it will integrate its research and development and technical operations teams alongside its global and North American commercial organizations into a co-located innovation hub, adding that the lease deal is with a new joint venture collaboration between MIT Investment Management and Blackstone (BX) Real Estate portfolio company BioMed Realty, which is constructing the new building.
Price: 141.36, Change: +0.46, Percent Change: +0.33
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。